ARCHIVES

Congress Approves More Favorable Terms for Office-Administered Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 31 | August 8, 1997

Download PDF Visit The Full Archive

Related Articles

Health Groups Urge FDA To Regulate Tobacco Products, Including E-Cigarettes

September 5, 2014

NCI Cooperative Group, Cancer Center Trials Listed

February 27, 2009

ORI Finds Misconduct By Harvard Physician On Cancer Protocol; Two Other Cases

June 9, 1995

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

“Mind Boggling” Results Reported In Trials Using 3-Drug Combination For Breast Cancer

October 10, 1975

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000